Home › Cases › Amaurosis Fugax at Seventy-Four
Giant Cell Arteritis
Amaurosis Fugax at Seventy-Four
6 questions
Question 1 · The Features
Correct answer: Jaw claudication
Why
Jaw claudication is the most specific feature of giant cell arteritis.
- The full picture: age over 50, new headache, jaw claudication, scalp tenderness, and raised ESR or CRP
- Visual symptoms — amaurosis fugax, diplopia, blurring — mean impending irreversible blindness
- ESR and CRP are normal in around 5%, so normal inflammatory markers do not exclude it
- Headache and scalp tenderness are sensitive but far less specific — plenty of causes produce both
- Jaw claudication is pain on chewing that eases with rest, which is why the mechanical history matters
Key point
Jaw claudication is the most specific feature. And normal inflammatory markers do not exclude GCA.
Question 2 · What To Give
Correct answer: IV methylprednisolone 500mg to 1g daily for 3 days, immediately — visual symptoms mean impending irreversible blindness
Why
Visual symptoms mean IV methylprednisolone 500mg to 1g daily for 3 days, given immediately.
- Prednisolone 40 to 60mg orally is for GCA WITHOUT visual symptoms — she has them
- Never wait for the biopsy. The pathway states it, and adds the reassurance that steroids do not obscure the biopsy for 2 to 6 weeks, so there is no diagnostic cost to treating first
- Once the second eye is lost, no treatment recovers it — the entire urgency is about the fellow eye
- Then convert to high-dose oral prednisolone
Key point
IV methylprednisolone now, biopsy later. Steroids do not obscure the biopsy for 2–6 weeks.
Question 3 · Referrals
Correct answer: Ophthalmology the same day because of the visual symptoms, and rheumatology via the fast-track GCA pathway
Why
Visual symptoms mean ophthalmology the same day. All GCA goes to rheumatology via the fast-track GCA pathway.
- Most regions have a fast-track pathway precisely because delays cost sight, and using it is faster than a standard referral
- Any visual symptom is an escalation trigger: IV steroids now plus same-day ophthalmology
- A routine rheumatology referral in a patient with amaurosis fugax misses the point of the pathway
- Two weeks is the timescale for the biopsy, not for the ophthalmology review
Key point
Ophthalmology today, rheumatology fast-track. The pathway exists because delay costs eyes.
Question 4 · Confirming
Correct answer: Temporal artery ultrasound looking for the halo sign, and biopsy within 2 weeks of starting steroids — noting that skip lesions occur
Why
Temporal artery ultrasound — the halo sign — and biopsy within 2 weeks of starting steroids. Skip lesions occur.
- Skip lesions mean the artery is not uniformly involved, so a negative biopsy does not exclude GCA — an adequate length of vessel is needed and the result is interpreted clinically
- Ultrasound is increasingly used first in fast-track pathways: non-invasive and immediate
- Biopsy before steroids is not required and would delay treatment for no benefit, since the histology persists for 2 to 6 weeks
- ESR and CRP support the diagnosis but are normal in about 5%
Key point
Halo sign on ultrasound, biopsy within two weeks — and skip lesions mean a negative biopsy proves nothing.
Question 5 · The Package
Correct answer: Aspirin 75mg per local policy, a PPI, bone protection with alendronic acid plus calcium and vitamin D, and glucose monitoring
Why
Aspirin 75mg per local policy — it may reduce ischaemic events — plus a PPI, bone protection and glucose monitoring.
- Alendronic acid 70mg weekly with calcium and vitamin D, because GCA means months to two years of steroids and fracture risk is substantial
- Glucose monitoring, since steroid-induced hyperglycaemia is common
- Watch the fellow eye — fellow-eye symptoms developing on treatment is an escalation trigger
- Bone protection is the element most often forgotten at initiation and hardest to retrofit
- Prophylactic antibiotics are not indicated
Key point
Start the bone protection on day one. Two years of steroids is coming, and it is never added later.
Question 6 · The Long Game
Correct answer: A slow rheumatology-led taper over months to two years, with tocilizumab or methotrexate for relapsing disease — and PMR overlap in 40–60%
Why
Months to two years of steroids, rheumatology-led, tapered slowly.
- Tocilizumab or methotrexate for relapsing disease — steroid-sparing agents matter enormously given the cumulative dose
- Polymyalgia rheumatica overlaps in 40 to 60%, so proximal girdle pain and stiffness should be asked about
- Relapse during the taper is an escalation trigger for rheumatology
- A six-week course would guarantee relapse; lifelong high-dose steroid would cause enormous harm
- Also consider limb claudication or aortic involvement, which needs vascular imaging — GCA is a large-vessel vasculitis, not only a temporal artery disease
Key point
Months to two years, tapered slowly, with steroid-sparing agents for relapse. And ask about PMR.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.